Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1321 AL 1335

Glucocerebrosidase Mutations in Parkinson Disease

O'Regan G, deSouza RM, Balestrino R, Schapira AH.

J Parkinsons Dis. 2017;7(3):411-422. doi: 10.3233/JPD-171092.

Important medicinal herbs in Parkinson's disease pharmacotherapy

Srivastav S, Fatima M, Mondal AC.

Biomed Pharmacother. 2017 Aug;92:856-863. doi: 10.1016/j.biopha.2017.05.137. Epub 2017 Jun 6.

Evidence based effects of yoga in neurological disorders

Mooventhan A, Nivethitha L.

J Clin Neurosci. 2017 Sep;43:61-67. doi: 10.1016/j.jocn.2017.05.012. Epub 2017 Jun 7.

Tracking and predicting disease progression in progressive supranuclear palsy: CSF and blood biomarkers

Jabbari E, Zetterberg H, Morris HR.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):883-888. doi: 10.1136/jnnp-2017-315857. Epub 2017 Jun 9.

Hiccups in Parkinson's disease: an analysis of cases reported in the European pharmacovigilance database and a review of the literature

Lertxundi U, Marquínez AC, Domingo-Echaburu S, Solinís MÁ, Calvo B, Del Pozo-Rodríguez A, García M, Aguirre C, Isla A.

Eur J Clin Pharmacol. 2017 Sep;73(9):1159-1164. doi: 10.1007/s00228-017-2275-6. Epub 2017 Jun 9.

Brain Autoimmunity and Intestinal Microbiota: 100 Trillion Game Changers

Wekerle H.

Trends Immunol. 2017 Jul;38(7):483-497. doi: 10.1016/j.it.2017.03.008. Epub 2017 Jun 7.

The impact of Tai Chi and Qigong mind-body exercises on motor and non-motor function and quality of life in Parkinson's disease: A systematic review and meta-analysis

Song R, Grabowska W, Park M, Osypiuk K, Vergara-Diaz GP, Bonato P, Hausdorff JM, Fox M, Sudarsky LR, Macklin E, Wayne PM.

Parkinsonism Relat Disord. 2017 Aug;41:3-13. doi: 10.1016/j.parkreldis.2017.05.019. Epub 2017 May 25.

Dopamine and the Brainstem Locomotor Networks: From Lamprey to Human

Ryczko D, Dubuc R.

Front Neurosci. 2017 May 26;11:295. doi: 10.3389/fnins.2017.00295. eCollection 2017.

Iodine-123-meta-iodobenzylguanidine Myocardial Scintigraphy in Isolated Autonomic Failure: Potential Red Flag for Future Multiple System Atrophy

Baschieri F, Calandra-Buonaura G, Cecere A, Barletta G, Contin M, Parchi P, Cortelli P.

Front Neurol. 2017 May 26;8:225. doi: 10.3389/fneur.2017.00225. eCollection 2017.

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson's disease

Farotti L, Paciotti S, Tasegian A, Eusebi P, Parnetti L.

Expert Rev Mol Diagn. 2017 Aug;17(8):771-780. doi: 10.1080/14737159.2017.1341312. Epub 2017 Jun 19.

Spirituality As a Coping Mechanism for Individuals with Parkinson's Disease

Reynolds D.

J Christ Nurs. 2017 Jul/Sep;34(3):190-194. doi: 10.1097/CNJ.0000000000000392.

ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial

Pahwa R, Tanner CM, Hauser RA, Isaacson SH, Nausieda PA, Truong DD, Agarwal P, Hull KL, Lyons KE, Johnson R, Stempien MJ.

JAMA Neurol. 2017 Aug 1;74(8):941-949. doi: 10.1001/jamaneurol.2017.0943.

Targeted temperature management after out-of-hospital cardiac arrest in three young patients

Godinjak A, Iglica A, Kukuljac A, Tančica I, Jusufović S, Ajanović A, Rožajac Š.

Acta Med Acad. 2017 May;46(1):50-54. doi: 10.5644/ama2006-124.186.

Computer-assisted cognitive rehabilitation on freezing of gait in Parkinson's disease: A pilot study

Dibilio V, Nicoletti A, Mostile G, Portaro G, Luca A, Patti F, Zappia M.

Neurosci Lett. 2017 Jul 27;654:38-41. doi: 10.1016/j.neulet.2017.06.006. Epub 2017 Jun 9.

Novel evidence associates higher plasma α-synuclein levels and cognitive impairment in Parkinson's disease

Aarsland D, Rajkumar AP, Hye A.

J Neurol Neurosurg Psychiatry. 2017 Oct;88(10):808. doi: 10.1136/jnnp-2017-315821. Epub 2017 Jun 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias